400-821-0725
| 规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
|---|---|---|---|---|---|---|---|---|---|
| 10g | ￥ ŠljƓƈƈ | > 10 | 2 | -- | -- | -- | -- | ￥ ŠljƓƈƈ | - + |
| 25g | ￥ ÈŠƓƈƈ | > 10 | 1 | -- | -- | -- | -- | ￥ ÈŠƓƈƈ | - + |
| 100g | ￥ ĻĬĻƓƈƈ | > 10 | -- | -- | -- | -- | -- | ￥ ĻĬĻƓƈƈ | - + |
| 500g | ￥ ljljĬƞƓƈƈ | > 10 | -- | -- | -- | -- | -- | ￥ ljljĬƞƓƈƈ | - + |
| 1000g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
| 大货 | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
158.02
[1]. Bjarne G Hansen, et al. A new class of IMP dehydrogenase with a role in self-resistance of mycophenolic acid producing fungi. BMC Microbiol. 20 Sep 1::202.
[2]. Helen R Josephine, et al. The Cys19 loop modulates the transition between dehydrogenase and hydrolase conformations in inosine 5 -monophosphate dehydrogenase. Biochemistry. 2010 Dec 21;49(50):1074-81.
[]. L Hedstrom, et al. The antibiotic potential of prokaryotic IMP dehydrogenase inhibitors. Curr Med Chem. 20;18(1):1909-18.
[4]. Sofie Haglund, et al. The role of inosine-5 -monophosphate dehydrogenase in thiopurine metabolism in patients with inflammatory bowel disease. Ther Drug Monit. 20 Apr;(2):200-8.
[5]. Tomonori Nakanishi, et al. Effect of the inosine 5 -monophosphate dehydrogenase inhibitor BMS-5419 on rat cardiac allograft rejection. Int Immunopharmacol. 2010 Jan;10(1):91-7.
H02-H15-H19-H5
P21-P24-P270-P271-P280-P02+P52-P04+P40-P05+P51+P8-P0-P2+P4-P40+P2-P405-P501
沪ICP备1701945号
